Pinilla-Ibarz J - Search Results

1

Electrocardiographic Changes Associated With Ibrutinib Exposure.

Fradley MG, Welter-Frost A, Gliksman M, Emole J, Viganego F, Lee DH, Shah B, Chavez JC, Pinilla-Ibarz J, Schabath MB. Fradley MG, et al. Cancer Control. 2020 Jan-Dec;27(1):1073274820931808. doi: 10.1177/1073274820931808. Cancer Control. 2020. PMID: 32496158 Free PMC article.

2

Clinical and therapeutic implications of the mutational status of IgVH in patients with chronic lymphocytic leukemia.

Kharfan-Dabaja MA, Chavez JC, Khorfan KA, Pinilla-Ibarz J. Kharfan-Dabaja MA, et al. Cancer. 2008 Sep 1;113(5):897-906. doi: 10.1002/cncr.23671. Cancer. 2008. PMID: 18618518 Free article. Review.

3

Signaling networks associated with BCR-ABL-dependent transformation.

Hazlehurst LA, Bewry NN, Nair RR, Pinilla-Ibarz J. Hazlehurst LA, et al. Cancer Control. 2009 Apr;16(2):100-7. doi: 10.1177/107327480901600202. Cancer Control. 2009. PMID: 19337196 Free article. Review.

4

The biological basis for immunotherapy in patients with chronic myelogenous leukemia.

Pinilla-Ibarz J, Shah B, Dubovsky JA. Pinilla-Ibarz J, et al. Cancer Control. 2009 Apr;16(2):141-52. doi: 10.1177/107327480901600206. Cancer Control. 2009. PMID: 19337200 Free article. Review.

5

Chronic lymphocytic leukemia: putting new treatment options into perspective.

Pinilla-Ibarz J, McQuary A. Pinilla-Ibarz J, et al. Cancer Control. 2010 Apr;17(2 Suppl):4-15; quiz 16. doi: 10.1177/1073274810017002S03. Cancer Control. 2010. PMID: 20404796 Free article. Review.

6

Front-line therapy for chronic lymphocytic leukemia.

Desai S, Pinilla-Ibarz J. Desai S, et al. Cancer Control. 2012 Jan;19(1):26-36. doi: 10.1177/107327481201900104. Cancer Control. 2012. PMID: 22143060 Free article. Review.

7

Treatment of relapsed or refractory chronic lymphocytic leukemia.

Veliz M, Pinilla-Ibarz J. Veliz M, et al. Cancer Control. 2012 Jan;19(1):37-53. doi: 10.1177/107327481201900105. Cancer Control. 2012. PMID: 22143061 Free article. Review.

8

Immunomodulatory drugs and active immunotherapy for chronic lymphocytic leukemia.

Carballido E, Veliz M, Komrokji R, Pinilla-Ibarz J. Carballido E, et al. Cancer Control. 2012 Jan;19(1):54-67. doi: 10.1177/107327481201900106. Cancer Control. 2012. PMID: 22143062 Free article. Review.

9

Stat3 inhibition augments the immunogenicity of B-cell lymphoma cells, leading to effective antitumor immunity.

Cheng F, Wang H, Horna P, Wang Z, Shah B, Sahakian E, Woan KV, Villagra A, Pinilla-Ibarz J, Sebti S, Smith M, Tao J, Sotomayor EM. Cheng F, et al. Cancer Res. 2012 Sep 1;72(17):4440-8. doi: 10.1158/0008-5472.CAN-11-3619. Epub 2012 Jun 22. Cancer Res. 2012. PMID: 22728650 Free PMC article.

10

Developing strategies in the immunotherapy of leukemias.

Brayer JB, Pinilla-Ibarz J. Brayer JB, et al. Cancer Control. 2013 Jan;20(1):49-59. doi: 10.1177/107327481302000108. Cancer Control. 2013. PMID: 23302907 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

179 results

Search Page

Filters